Synopsys, Inc. logo

Synopsys, Inc. (SNPS)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
454. 63
-13.48
-2.8797%
$
96.22B Market Cap
70.41 P/E Ratio
- Div Yield
2.52M Volume
11.08 Eps
$ 468.11
Previous Close
Add Transaction
Day Range
448.19 469.03
Year Range
362.55 539.48
Want to track SNPS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Synopsys offers remedies to address EU concerns over Ansys deal

Synopsys offers remedies to address EU concerns over Ansys deal

Chip design software company Synopsys has offered remedies to address EU antitrust concerns about its $35 billion cash-and-stock acquisition of engineering software maker Ansys , according to a European Commission filing on Tuesday.

Reuters | 1 year ago
Synopsys: The Downside When Stocks Are Priced To The Point Of Perfection

Synopsys: The Downside When Stocks Are Priced To The Point Of Perfection

Synopsys' recent stock price drop is justified due to lower-than-expected FY25 guidance, impacting the 5-year outlook and reducing upside potential. Synopsys remains a dominant player in the EDA and IP markets, but a high multiple and shareholder dilution pose risks to future returns. I have downgraded Synopsys to Hold due to weaker guidance, economic uncertainties, and the potential for better entry points.

Seekingalpha | 1 year ago
Wall Street Bulls Look Optimistic About Synopsys (SNPS): Should You Buy?

Wall Street Bulls Look Optimistic About Synopsys (SNPS): Should You Buy?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Zacks | 1 year ago
S&P 500 Gains and Losses Today: Synopsys Sinks as China Restrictions Hurt Outlook

S&P 500 Gains and Losses Today: Synopsys Sinks as China Restrictions Hurt Outlook

Major U.S. equities indexes hovered near record levels in Thursday trading before closing lower ahead of Friday morning's employment report.

Investopedia | 1 year ago
Synopsys Q4: Anticipating Revenue Deceleration In FY 2025; Remain 'Sell'

Synopsys Q4: Anticipating Revenue Deceleration In FY 2025; Remain 'Sell'

Synopsys, Inc.'s stock remains overvalued despite 11% revenue growth and weak guidance, reiterating a “Sell” rating with a fair value of $394 per share. The acquisition of Ansys for $35 billion is strategically favorable, promising synergies and integration benefits in the semiconductor design and simulation markets. Weak end-market demands and a pessimistic outlook for China's semiconductor industry are expected to hinder Synopsys's growth in FY25.

Seekingalpha | 1 year ago
Synopsys Stock Is the S&P 500's Worst Performer Today

Synopsys Stock Is the S&P 500's Worst Performer Today

Synopsys (SNPS) shares tumbled after the chip design software maker posted a disappointing forecast for its coming fiscal year late Wednesday.

Investopedia | 1 year ago
Synopsys Stock Dives On Outlook. Another AI Red Flag?

Synopsys Stock Dives On Outlook. Another AI Red Flag?

Synopsys stock plunged after the chip design company guided low on revenue, though some analysts remain upbeat. The post Synopsys Stock Dives On Outlook.

Investors | 1 year ago
SNPS CFO on Role in A.I. Race, Cut Guidance & Ansys Acquisition

SNPS CFO on Role in A.I. Race, Cut Guidance & Ansys Acquisition

Shelagh Glaser, CFO of Synopsys (SNPS), discusses the direction she aims to take the company after investors traded the stock down. She explains part of the reason Synopsys cut guidance was due to the setup of the calendar year, reiterating that revenue growth shows promise in its outlook.

Youtube | 1 year ago
Synopsys Q4 Earnings Beat Estimates, Stock Dips 7% on Weak Guidance

Synopsys Q4 Earnings Beat Estimates, Stock Dips 7% on Weak Guidance

SNPS' Q4 results reflect an impressive rise in top and bottom lines, driven by strong growth across multiple business segments.

Zacks | 1 year ago
Synopsys, Inc. (SNPS) Q4 2024 Earnings Call Transcript

Synopsys, Inc. (SNPS) Q4 2024 Earnings Call Transcript

Synopsys, Inc. (NASDAQ:SNPS ) Q4 2024 Earnings Conference Call December 4, 2024 4:30 PM ET Company Participants Trey Campbell - Senior Vice President, Investor Relations Sassine Ghazi - President and Chief Executive Officer Shelagh Glaser - Chief Financial Officer Conference Call Participants Joe Vruwink - Baird Jason Celino - KeyBanc Capital Markets Harlan Sur - J.P. Morgan Vivek Arya - Bank of America Gary Mobley - Loop Capital Jay Vleeschhouwer - Griffin Securities Ruben Roy - Stifel Charles Shi - Needham & Company Joshua Tilton - Wolfe Research Operator Ladies and gentlemen, welcome to the Synopsys Earnings Conference Call for the Fourth Quarter and Fiscal Year 2024.

Seekingalpha | 1 year ago
Compared to Estimates, Synopsys (SNPS) Q4 Earnings: A Look at Key Metrics

Compared to Estimates, Synopsys (SNPS) Q4 Earnings: A Look at Key Metrics

The headline numbers for Synopsys (SNPS) give insight into how the company performed in the quarter ended October 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 1 year ago
Synopsys (SNPS) Q4 Earnings and Revenues Top Estimates

Synopsys (SNPS) Q4 Earnings and Revenues Top Estimates

Synopsys (SNPS) came out with quarterly earnings of $3.40 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.17 per share a year ago.

Zacks | 1 year ago
Loading...
Load More